Aqualyx (10 vials x 8 ml)

Patients must strictly avoid alcohol for 24h before and 48h after the procedure. Alcohol is a vasodilator and can interfere with liver metabolism, potentially slowing the elimination of dissolved fats and worsening edema in the treated areas.

The formulation contains a polymer of 3,6-anhydro-L-galactose and D-galactose, buffer systems, and a sodium salt of 12-alfa-dihydroxy-5-beta-24-oico cholanic acid.

Not advised while breastfeeding due to insufficient evidence on possible excretion into breast milk and infant safety. Procedures should be deferred until after breastfeeding is completed.

Aqualyx works by causing the lysis (destruction) of the fat cell membrane. Once the cell is ruptured, the fatty acids are released and naturally metabolized by the liver and excreted through the kidneys. Unlike superficial skin boosters, which prioritize dermal hydration, Aqualyx acts on the hypodermal layer to physically reduce the number of fat cells for permanent contouring results.

This treatment is strictly contraindicated. No clinical safety data exists for deoxycholate-based solutions during pregnancy. All elective body contouring procedures should be deferred until after childbirth and the completion of the breastfeeding period.

Dosage is individualized based on the volume of the fat deposit. Typically, the maximum dose per session is 40 ml (5 vials) for body areas and 0.5 ml to 1.5 ml for facial areas like the double chin. Practitioners should evaluate if targeted micro-dosing is appropriate for early-stage jowls. A standard course consists of 2 to 8 sessions spaced 4 weeks apart to allow for proper lymphatic drainage.

Expect transient side effects such as localized swelling, heat sensation, and potential purple bruising at the injection sites. Because Aqualyx triggers an inflammatory fat-dissolving process, these reactions are normal signs of efficacy. To ensure a quick recovery, patients must follow our expert aftercare guide and utilize techniques to reduce post-injection swelling.